z-logo
open-access-imgOpen Access
Variation in Immunohistochemical Expression of Neuropilin 1 among Oral, Laryngeal and Skin SCC
Author(s) -
Khaled J. Abed,
Wassan H. Younis
Publication year - 2017
Publication title -
journal of baghdad college of dentistry
Language(s) - English
Resource type - Journals
eISSN - 2311-5270
pISSN - 1817-1869
DOI - 10.12816/0038625
Subject(s) - neuropilin 1 , immunohistochemistry , pathology , angiogenesis , medicine , immunoperoxidase , cancer , antibody , monoclonal antibody , vascular endothelial growth factor , cancer research , vegf receptors , immunology
Background: Neuropilin 1(NRP1) is considered a novel non tyrosine kinase coreceptor for the vascular endothelial growth factors (VEGF). First discovered on migrating neurons. NRP1is suggested to be up-regulated in cells of different types of cancer and implicated with advanced disease. The aim of this study was to investigate the variation in expression of NRP1 in oral, laryngeal and skin squamous cell carcinoma. Materials and methods: Tissue sections from 120 formalin fixedparaffin embedded blocks histopathologically diagnosed as oral, laryngeal and skin SCC (40 blocks for each),immunohistohemically stained in immunoperoxidase method with monoclonal antibodies to NRP1, the localization of expression was examined and the resulting scores were analyzed according to age, sex, and histopathological grades. Results: The immunohistochemical analysis revealed that the NRP1 expression in oral, laryngeal and skin squamous cell carcinoma was (87.5%), (92.2%) and (82.5%) respectively, with no significant variation in expression among them(P=0.44), but, NRP1 up-regulation in all the three types correlated positively with degree of differentiation (P=0.009), (P=0.002) and (P=0.007) respectively. Conclusion: Angiogenesis play an important and similar role in carcinogenesis of oral, laryngeal and skin squamous cell carcinoma, and NRP1 is significantly associated with degree of differentiation in the three types of carcinomaso it can be act as a prognostic marker.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom